Article
Parkinson's Disease-Associated Mutant LRRK2-Mediated Inhibition of miRNA Activity is Antagonized by TRIM32.
Molecular neurobiology - 1 Apr 2018
Gonzalez-Cano Laura, Menzl Ingeborg, Tisserand Johan, Nicklas Sarah, Schwamborn Jens C
Abstract excerpt
Parkinson's disease (PD) is the second most common neurodegenerative disorder. Accumulating evidences suggest that PD might have a strong neurodevelopmental component. Among the genetic cases, mutations in the leucine-rich repeat kinase 2 (LRRK2) are well known to be disease causing. Although the molecular mechanism of the pathogenic LRRK2 function is not fully clear, inhibition of microRNA (miRNA) activity has...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
